ANDREW REICHERT: Open Payments
NPI 1306849138 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,686 in 154 payments from 17 companies in 2025. Trend: 2023 $2,102 · 2024 $2,351 · 2025 $2,686
Food & beverage: $2,686
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 22 | $348 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $311 |
| Neurocrine BioSciences, Inc. | 8 | $240 |
| Lundbeck LLC | 15 | $237 |
| Collegium Pharmaceutical, Inc. | 11 | $222 |
| Janssen Pharmaceuticals, Inc | 9 | $213 |
| ABBVIE INC. | 13 | $195 |
| Takeda Pharmaceuticals U.S.A., Inc. | 24 | $185 |
| Teva Pharmaceuticals USA, Inc. | 8 | $174 |
| Bausch Health US, LLC | 8 | $153 |
Products named: REXULTI, CAPLYTA, INGREZZA, Jornay PM, SPRAVATO, VRAYLAR, AUSTEDO XR, TRINTELLIX.
Industry payments across NY — which companies pay providers there.
